Iveta Frysova

Title: Iveta Frysova: Innovator in Antimitotic and Therapeutic Compounds

Introduction

Iveta Frysova is a notable inventor based in Mohelnice, Czech Republic. She has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that have potential therapeutic applications.

Latest Patents

Iveta Frysova holds a patent for "4-arylazo-3,5-diamino-pyrazole compounds and use thereof." This patent describes a series of mono- and binuclear 4-arylazo-3,5-diamino-pyrazoles that are useful for inhibiting cyclin-dependent kinases, specifically CDK9. These compounds have a wide range of applications, including their use as antimitotic, pro-apoptotic, and anti-inflammatory drugs. They are particularly relevant in the chemotherapy of cancer and asthma, as well as in the treatment of psoriasis, parasitoses, and Alzheimer's disease. Additionally, these compounds can serve as intermediates in the preparation of flame-retardants, diagnostic reagents, and therapeutics, including antivirals and immunosuppressors. Iveta has been granted 1 patent for her innovative work.

Career Highlights

Iveta Frysova is affiliated with the Palacký University Olomouc, where she continues her research and development efforts. Her work has positioned her as a key figure in the field of medicinal chemistry, contributing to advancements that may lead to improved therapeutic options for various diseases.

Collaborations

Throughout her career, Iveta has collaborated with notable colleagues, including Petr Cankar and Vladimir Krystof. These collaborations have further enriched her research and expanded the impact of her innovations.

Conclusion

Iveta Frysova is a pioneering inventor whose work in developing therapeutic compounds showcases her commitment to advancing medical science. Her contributions have the potential to significantly impact the treatment of various diseases, highlighting the importance of innovation in healthcare.